Weight-Loss drugs tested as potential cancer treatment
NCT ID NCT07107334
Summary
This study is testing whether popular weight-loss medications (GLP-1RAs) can help treat early-stage endometrial cancer when used alongside a hormonal IUD. It is for obese patients who are not good candidates for surgery or who wish to preserve their fertility. The goal is to see if this drug combination can clear the cancer or control it, potentially offering a non-surgical treatment option.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Florida
RECRUITINGGainesville, Florida, 32608, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.